Grants and Contracts Details
| Status | Active |
|---|---|
| Effective start/end date | 7/25/23 → 7/25/25 |
Funding
- ReAlta Life Sciences Incorporated: $16,600.00
STAR: A Phase 2, Two-Stage, Randomized, Double-Blind, Placebo-Controlled, Multiple-Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of RLS-0071 in Newborns with Moderate or Severe Hypoxic-Ischemic Encep
- Torgalkar, Ranjit (PI)
- Bauer, John (CoI)
- Hanna, Mina (CoI)
- Giannone, Peter (Former PI)